Anderson ST, Commins S, Moynagh PN, Coogan AN. Lipopolysaccharide-induced sepsis induces long-lasting affective changes in the mouse. Brain. Behav. Immun. 2015 Jan;43:98–109.
Ayorech Z, Tracy DK, Baumeister D, Giaroli G. Taking the fuel out of the fire: evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders. J. Affect. Disord. 2015 Mar 15;174:467–78.
Barrot M, Olivier JDA, Perrotti LI, DiLeone RJ, Berton O, Eisch AJ, et al. CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc. Natl. Acad. Sci. U. S. A. 2002 Aug 20;99(17):11435–40.
Benedetti F, Poletti S, Hoogenboezem TA, Locatelli C, de Wit H, Wijkhuijs AJM, et al. Higher Baseline Proinflammatory Cytokines Mark Poor Antidepressant Response in Bipolar Disorder. J. Clin. Psychiatry. 2017 Oct;78(8):e986–93.
Berk M, Dodd S, Kauer-Sant’Anna M, Malhi GS, Bourin M, Kapczinski F, et al. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr. Scand. 2007 Oct 1;116:41–9.
Berk M, Williams LJ, Jacka FN, O’Neil A, Pasco JA, Moylan S, et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013 Sep 12;11(1):200.
Beyer DKE, Freund N. Animal models for bipolar disorder: from bedside to the cage. Int. J. Bipolar Disord. 2017 Oct 13;5:35.
Bossù P, Cutuli D, Palladino I, Caporali P, Angelucci F, Laricchiuta D, et al. A single intraperitoneal injection of endotoxin in rats induces long-lasting modifications in behavior and brain protein levels of TNF-α and IL-18. J. Neuroinflammation. 2012 May 29;9(1):101.
Boufidou F, Nikolaou C, Alevizos B, Liappas IA, Christodoulou GN. Cytokine production in bipolar affective disorder patients under lithium treatment. J. Affect. Disord. 2004 Oct 15;82(2):309–13.
Brietzke E, Kauer-Sant’anna M, Teixeira AL, Kapczinski F. Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder. Brain. Behav. Immun. 2009a Nov;23(8):1079–82.
Brietzke E, Stertz L, Fernandes BS, Kauer-Sant’Anna M, Mascarenhas M, Escosteguy Vargas A, et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J. Affect. Disord. 2009b Aug;116(3):214–7.
Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. 1993 Nov 1;90(21):10061–5.
Campbell IL, Erta M, Lim SL, Frausto R, May U, Rose-John S, et al. Trans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain. J. Neurosci. 2014 Feb 12;34(7):2503–13.
Capuron L, Pagnoni G, Demetrashvili MF, Lawson DH, Fornwalt FB, Woolwine B, et al. Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2007 Nov;32(11):2384–92.
Capuron L, Pagnoni G, Drake DF, Woolwine BJ, Spivey JR, Crowe RJ, et al. Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch. Gen. Psychiatry. 2012 Oct;69(10):1044–53.
Capuron L, Ravaud A, Miller AH, Dantzer R. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain. Behav. Immun. 2004 May;18(3):205–13.
Comim CM, Cassol-Jr OJ, Constantino LC, Petronilho F, Constantino LS, Stertz L, et al. Depressive-Like Parameters in Sepsis Survivor Rats. Neurotox. Res. 2010 Apr 1;17(3):279–86.
de Cossío LF, Fourrier C, Sauvant J, Everard A, Capuron L, Cani PD, et al. Impact of prebiotics on metabolic and behavioral alterations in a mouse model of metabolic syndrome. Brain. Behav. Immun. 2017 Aug;64:33–49.
Dalley JW, Fryer TD, Brichard L, Robinson ESJ, Theobald DEH, Lääne K, et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science. 2007 Mar 2;315(5816):1267–70.
Davis RL, Stevens CW, Thomas Curtis J. The opioid antagonist, β-funaltrexamine, inhibits lipopolysaccharide-induced neuroinflammation and reduces sickness behavior in mice. Physiol. Behav. 2017 01;173:52–60.
Di Caprio R, Lembo S, Di Costanzo L, Balato A, Monfrecola G. Anti-Inflammatory Properties of Low and High Doxycycline Doses: An In Vitro Study [Internet]. Mediators Inflamm. 2015 [cited 2019 Dec 4]. Available from: https://www.hindawi.com/journals/mi/2015/329418/
Dinel A-L, André C, Aubert A, Ferreira G, Layé S, Castanon N. Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome. PloS One. 2011;6(9):e24325.
DiSabato D, Quan N, Godbout JP. Neuroinflammation: The Devil is in the Details. J. Neurochem. 2016 Oct;139(Suppl 2):136–53.
D’Mello C, Ronaghan N, Zaheer R, Dicay M, Le T, MacNaughton WK, et al. Probiotics Improve Inflammation-Associated Sickness Behavior by Altering Communication between the Peripheral Immune System and the Brain. J. Neurosci. Off. J. Soc. Neurosci. 2015 Jul 29;35(30):10821–30.
Eisenberger NI, Berkman ET, Inagaki TK, Rameson LT, Mashal NM, Irwin MR. Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol. Psychiatry. 2010 Oct 15;68(8):748–54.
van Enkhuizen J, Geyer MA, Minassian A, Perry W, Henry BL, Young JW. Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies. Neurosci. Biobehav. Rev. 2015 Nov;58:4–18.
Fattori E, Lazzaro D, Musiani P, Modesti A, Alonzi T, Ciliberto G. IL-6 Expression in Neurons of Transgenic Mice Causes Reactive Astrocytosis and Increase in Ramified Microglial Cells but no Neuronal Damage. Eur. J. Neurosci. 1995;7(12):2441–9.
Felger JC. Imaging the Role of Inflammation in Mood and Anxiety-related Disorders. Curr. Neuropharmacol. 2018;16(5):533–58.
Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, et al. Multiple sclerosis. Nat. Rev. Dis. Primer. 2018 08;4(1):43.
Fischer CW, Eskelund A, Budac DP, Tillmann S, Liebenberg N, Elfving B, et al. Interferon-alpha treatment induces depression-like behaviour accompanied by elevated hippocampal quinolinic acid levels in rats. Behav. Brain Res. 2015 Oct 15;293:166–72.
Freund N, Thompson BS, Sonntag K, Meda S, Andersen SL. When the party is over: depressive-like states in rats following termination of cortical D1 receptor overexpression. Psychopharmacology (Berl.). 2016 Apr;233(7):1191–201.
Fu X, Zunich SM, O’Connor JC, Kavelaars A, Dantzer R, Kelley KW. Central Administration of Lipopolysaccharide Induces Depressive-like Behavior in Vivo and Activates Brain Indoleamine 2,3 Dioxygenase In Murine Organotypic Hippocampal Slice Cultures. J. Neuroinflammation. 2010 Aug 2;7(1):43.
Gage GJ, Kipke DR, Shain W. Whole animal perfusion fixation for rodents. J. Vis. Exp. JoVE. 2012 Jul 30;(65).
Goes FS. The importance of anxiety states in bipolar disorder. Curr. Psychiatry Rep. 2015 Feb;17(2):3.
Goldberg D, Fawcett J. The importance of anxiety in both major depression and bipolar disorder. Depress. Anxiety. 2012 Jun;29(6):471–8.
Goldsmith DR, Haroon E, Woolwine BJ, Jung MY, Wommack EC, Harvey PD, et al. Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder. Brain. Behav. Immun. 2016a Aug;56:281–8.
Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol. Psychiatry. 2016b;21(12):1696–709.
Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J. Clin. Psychiatry. 2009 Aug;70(8):1078–90.
Gonul AS, Coburn K, Kula M. Cerebral blood flow, metabolic, receptor, and transporter changes in bipolar disorder: the role of PET and SPECT studies. Int. Rev. Psychiatry Abingdon Engl. 2009;21(4):323–35.
Gründer G, Cumming P. Chapter 7 - The Dopamine Hypothesis of Schizophrenia: Current Status. In: Abel T, Nickl-Jockschat T, editors. Neurobiol. Schizophr. [Internet]. San Diego: Academic Press; 2016 [cited 2019 Nov 27]. p. 109–24. Available from: http://www.sciencedirect.com/science/article/pii/B978012801829300015X
Guloksuz S, Altinbas K, Aktas Cetin E, Kenis G, Bilgic Gazioglu S, Deniz G, et al. Evidence for an association between tumor necrosis factor-alpha levels and lithium response. J. Affect. Disord. 2012 Dec 20;143(1):148–52.
Han X, Li B, Ye X, Mulatibieke T, Wu J, Dai J, et al. Dopamine D2 receptor signalling controls inflammation in acute pancreatitis via a PP2A-dependent Akt/NF-κB signalling pathway. Br. J. Pharmacol. 2017 Dec;174(24):4751–70.
Hannestad J, DellaGioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2011 Nov;36(12):2452–9.
Hare BD, Shinohara R, Liu RJ, Pothula S, DiLeone RJ, Duman RS. Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects. Nat. Commun. [Internet]. 2019 Jan 15 [cited 2019 Jan 24];10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333924/
Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2012 Jan;37(1):137–62.
Ikeda-Dantsuji Y, Konomi I, Nagayama A. Effects of levofloxacin and doxycycline on interleukin-6 production of Chlamydia trachomatis-infected human synovial fibroblasts. Chemotherapy. 2007;53(5):332–7.
Jangra A, Lukhi MM, Sulakhiya K, Baruah CC, Lahkar M. Protective effect of mangiferin against lipopolysaccharide-induced depressive and anxiety-like behaviour in mice. Eur. J. Pharmacol. 2014 Oct 5;740:337–45.
Kamata M, Higuchi H, Yoshimoto M, Yoshida K, Shimizu T. Effect of single intracerebroventricular injection of alpha-interferon on monoamine concentrations in the rat brain. Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 2000 Mar;10(2):129–32.
Kaster MP, Gadotti VM, Calixto JB, Santos ARS, Rodrigues ALS. Depressive-like behavior induced by tumor necrosis factor-α in mice. Neuropharmacology. 2012 Jan 1;62(1):419–26.
Kato T, Kubota M, Kasahara T. Animal models of bipolar disorder. Neurosci. Biobehav. Rev. 2007;31(6):832–42.
Kitagami T, Yamada K, Miura H, Hashimoto R, Nabeshima T, Ohta T. Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood-brain barrier. Brain Res. 2003 Jul 18;978(1–2):104–14.
Knijff EM, Breunis MN, Kupka RW, de Wit HJ, Ruwhof C, Akkerhuis GW, et al. An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment. Bipolar Disord. 2007 Nov;9(7):743–53.
Köhler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry. 2014 Dec 1;71(12):1381–91.
Kucuk A, Kabadere S, Tosun M, Koken T, Kinaci MK, Isikli B, et al. Protective effects of doxycycline in ischemia/reperfusion injury on kidney. J. Physiol. Biochem. 2009 Jun;65(2):183–91.
Lacosta S, Merali Z, Anisman H. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res. 1999 Feb 13;818(2):291–303.
Leonard BE. Impact of inflammation on neurotransmitter changes in major depression: An insight into the action of antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2014 Jan 3;48:261–7.
Liu L, Zhang L, Wang T, Chen L. Dopamine D1 receptor in the medial prefrontal cortex mediates anxiety-like behaviors induced by blocking glutamatergic activity of the ventral hippocampus in rats. Brain Res. 2019a 01;1704:59–67.
Liu L, Zhang Q, Cai Y, Sun D, He X, Wang L, et al. Resveratrol counteracts lipopolysaccharide-induced depressive-like behaviors via enhanced hippocampal neurogenesis. Oncotarget. 2016 Aug 30;7(35):56045–59.
Liu T, Ma Y, Zhang R, Zhong H, Wang L, Zhao J, et al. Resveratrol ameliorates estrogen deficiency-induced depression- and anxiety-like behaviors and hippocampal inflammation in mice. Psychopharmacology (Berl.). 2019b Apr;236(4):1385–99.
Liu Y-M, Niu L, Wang L-L, Bai L, Fang X-Y, Li Y-C, et al. Berberine attenuates depressive-like behaviors by suppressing neuro-inflammation in stressed mice. Brain Res. Bull. 2017 Sep;134:220–7.
Lochhead JJ, Ronaldson PT, Davis TP. Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System. AAPS J. 2017 Jul;19(4):910–20.
Logan RW, McClung CA. Animal models of bipolar mania: The past, present and future. Neuroscience. 2016 May 3;321:163–88.
Lu Y-R, Rao Y-B, Mou Y-J, Chen Y, Lou H-F, Zhang Y, et al. High concentrations of serum interleukin-6 and interleukin-8 in patients with bipolar disorder. Medicine (Baltimore). 2019 Feb;98(7):e14419.
Ma L, Demin KA, Kolesnikova TO, Kharsko SL, Zhu X, Yuan X, et al. Animal inflammation-based models of depression and their application to drug discovery. Expert Opin. Drug Discov. 2017 Oct 3;12(10):995–1009.
Maes M. Major depression and activation of the inflammatory response system. Adv. Exp. Med. Biol. 1999;461:25–46.
Majer M, Welberg LAM, Capuron L, Pagnoni G, Raison CL, Miller AH. IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain. Behav. Immun. 2008 Aug;22(6):870–80.
Makino M, Kitano Y, Komiyama C, Takasuna K. Human interferon-α increases immobility in the forced swimming test in rats. Psychopharmacology (Berl.). 2000 Jan 1;148(1):106–10.
Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T. Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond. Neuropsychopharmacology. 2017 Jan;42(1):254–70.
Miller AH, Haroon E, Felger JC. Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2017;42(1):334–59.
Miller AH, Haroon E, Raison CL, Felger JC. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress. Anxiety. 2013 Apr;30(4):297–306.
Miller AH, Maletic V, Raison CL. Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression. Biol. Psychiatry. 2009 May 1;65(9):732–41.
Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol. Psychiatry. 2013 Jul 1;74(1):15–25.
Muneer A. Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers. Psychiatry Investig. 2016 Jan;13(1):18–33.
Na K-S, Jung H-Y, Kim Y-K. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2014 Jan 3;48:277–86.
Neurath MF, Finotto S. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev. 2011 Apr 1;22(2):83–9.
Nutt DJ. Relationship of neurotransmitters to the symptoms of major depressive disorder. J. Clin. Psychiatry. 2008;69 Suppl E1:4–7.
Onufriev MV, Freiman SV, Peregud DI, Kudryashova IV, Tishkina AO, Stepanichev MYu, et al. Neonatal proinflammatory stress induces accumulation of corticosterone and interleukin-6 in the hippocampus of juvenile rats: Potential mechanism of synaptic plasticity impairments. Biochem. Mosc. 2017 Mar 1;82(3):275–81.
Ortiz-Domínguez A, Hernández ME, Berlanga C, Gutiérrez-Mora D, Moreno J, Heinze G, et al. Immune variations in bipolar disorder: phasic differences. Bipolar Disord. 2007 Sep;9(6):596–602.
Pace TWW, Heim CM. A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain. Behav. Immun. 2011 Jan;25(1):6–13.
Pantazopoulos H, Stone D, Walsh J, Benes FM. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics. Synap. N. Y. N. 2004 Dec 1;54(3):147–55.
Paxinos G, Watson CR, Emson PC. AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J. Neurosci. Methods. 1980 Dec;3(2):129–49.
Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J. Neurosci. Off. J. Soc. Neurosci. 2001 Sep 15;21(18):7397–403.
Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong J-S, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55(5):453–62.
Raison CL, Miller AH. The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol. Psychiatry. 2013 Jan;18(1):15–37.
Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013 Jan;70(1):31–41.
Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry. 2001 May;58(5):445–52.
Remus JL, Dantzer R. Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery. Int. J. Neuropsychopharmacol. [Internet]. 2016 Sep 1 [cited 2017 May 23];19(9). Available from: https://academic.oup.com/ijnp/article/19/9/pyw028/2488254/Inflammation-Models-of-Depression-in-Rodents
Riazi K, Galic MA, Kentner AC, Reid AY, Sharkey KA, Pittman QJ. Microglia-dependent alteration of glutamatergic synaptic transmission and plasticity in the hippocampus during peripheral inflammation. J. Neurosci. Off. J. Soc. Neurosci. 2015 Mar 25;35(12):4942–52.
Rosenblat JD. Targeting the immune system in the treatment of bipolar disorder. Psychopharmacology (Berl.) [Internet]. 2019 Feb 13 [cited 2019 Sep 16]; Available from: https://doi.org/10.1007/s00213-019-5175-x
Salazar A, Gonzalez-Rivera BL, Redus L, Parrott JM, O’Connor JC. Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm. Behav. 2012 Aug 1;62(3):202–9.
Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S. The immunoregulatory role of dopamine: an update. Brain. Behav. Immun. 2010 May;24(4):525–8.
Schain M, Kreisl WC. Neuroinflammation in Neurodegenerative Disorders-a Review. Curr. Neurol. Neurosci. Rep. 2017;17(3):25.
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 2012 Jul;9(7):676–82.
Shal B, Khan A, Naveed M, Ullah Khan N, Ihsan-Ul-Haq null, D AlSharari S, et al. Effect of 25-methoxy hispidol A isolated from Poncirus trifoliate against bacteria-induced anxiety and depression by targeting neuroinflammation, oxidative stress and apoptosis in mice. Biomed. Pharmacother. Biomedecine Pharmacother. 2019 Mar;111:209–23.
Sharma AN, Fries GR, Galvez JF, Valvassori SS, Soares JC, Carvalho AF, et al. Modeling mania in preclinical settings: A comprehensive review. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2016 Apr 3;66:22–34.
Shuto H, Kataoka Y, Horikawa T, Fujihara N, Oishi R. Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain. Brain Res. 1997 Feb 7;747(2):348–51.
Simen BB, Duman CH, Simen AA, Duman RS. TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol. Psychiatry. 2006 May 1;59(9):775–85.
Skurlova M, Stofkova A, Jurcovicova J. Anxiety-like behavior in the elevated-plus maze tests and enhanced IL-1β, IL-6, NADPH oxidase-1, and iNOS mRNAs in the hippocampus during early stage of adjuvant arthritis in rats. Neurosci. Lett. 2011 Jan 7;487(2):250–4.
Soncini R, de Souza DF, Neves AP, Braga DS, Andrade CAF, Giusti-Paiva A. Dipyrone attenuates acute sickness response to lipopolysaccharide in mice. Neurosci. Lett. 2012 May 10;516(1):114–8.
Sonntag KC, Brenhouse HC, Freund N, Thompson BS, Puhl M, Andersen SL. Viral over-expression of D1 dopamine receptors in the prefrontal cortex increase high-risk behaviors in adults: comparison with adolescents. Psychopharmacology (Berl.). 2014 Apr;231(8):1615–26.
Stertz L, Magalhães PVS, Kapczinski F. Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr. Opin. Psychiatry. 2013 Jan;26(1):19–26.
Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA N. Y. N. 2003 Apr;9(4):493–501.
Suhara T, Nakayama K, Inoue O, Fukuda H, Shimizu M, Mori A, et al. D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology (Berl.). 1992 Jan 1;106(1):14–8.
Sulakhiya K, Keshavlal GP, Bezbaruah BB, Dwivedi S, Gurjar SS, Munde N, et al. Lipopolysaccharide induced anxiety- and depressive-like behaviour in mice are prevented by chronic pre-treatment of esculetin. Neurosci. Lett. 2016 Jan 12;611:106–11.
Sulakhiya K, Kumar P, Jangra A, Dwivedi S, Hazarika NK, Baruah CC, et al. Honokiol abrogates lipopolysaccharide-induced depressive like behavior by impeding neuroinflammation and oxido-nitrosative stress in mice. Eur. J. Pharmacol. 2014 Dec 5;744:124–31.
Tsai S-YM, Yang Y-Y, Kuo C-J, Chen C-C, Leu S-JC. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania. J. Affect. Disord. 2001 May 1;64(2):185–93.
Tuon L, Comim CM, Petronilho F, Barichello T, Izquierdo I, Quevedo J, et al. Time-dependent behavioral recovery after sepsis in rats. Intensive Care Med. 2008 Sep 1;34(9):1724–31.
Valvassori SS, Tonin PT, Varela RB, Carvalho AF, Mariot E, Amboni RT, et al. Lithium modulates the production of peripheral and cerebral cytokines in an animal model of mania induced by dextroamphetamine. Bipolar Disord. 2015 Aug;17(5):507–17.
Vázquez GH, Baldessarini RJ, Tondo L. Co-occurrence of anxiety and bipolar disorders: clinical and therapeutic overview. Depress. Anxiety. 2014 Mar;31(3):196–206.
Vogelzangs N, Beekman ATF, de Jonge P, Penninx BWJH. Anxiety disorders and inflammation in a large adult cohort. Transl. Psychiatry. 2013 Apr;3(4):e249.
Volkow ND, Fowler JS, Wang G-J, Hitzemann R, Logan J, Schlyer DJ, et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 1993;14(2):169–77.
Wachholz S, Knorr A, Mengert L, Plümper J, Sommer R, Juckel G, et al. Interleukin-4 is a participant in the regulation of depressive-like behavior. Behav. Brain Res. 2017 May 30;326:165–72.
Wadhwa M, Chauhan G, Roy K, Sahu S, Deep S, Jain V, et al. Caffeine and Modafinil Ameliorate the Neuroinflammation and Anxious Behavior in Rats during Sleep Deprivation by Inhibiting the Microglia Activation. Front. Cell. Neurosci. 2018;12:49.
Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2007 Feb;2(2):322–8.
Wang J, Duan P, Cui Y, Li Q, Shi Y. Geniposide alleviates depression-like behavior via enhancing BDNF expression in hippocampus of streptozotocin-evoked mice. Metab. Brain Dis. 2016 Oct 1;31(5):1113–22.
Wang N, Yu H-Y, Shen X-F, Gao Z-Q, Yang C, Yang J-J, et al. The rapid antidepressant effect of ketamine in rats is associated with down-regulation of pro-inflammatory cytokines in the hippocampus. Ups. J. Med. Sci. 2015;120(4):241–8.
Wang Q, Timberlake MA, Prall K, Dwivedi Y. The recent progress in animal models of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2017 Apr 8;77:99–109.
Wang Y-L, Han Q-Q, Gong W-Q, Pan D-H, Wang L-Z, Hu W, et al. Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats. J. Neuroinflammation. 2018 Jan 17;15(1):21.
van West D, Maes M. Activation of the inflammatory response system: A new look at the etiopathogenesis of major depression. Neuro Endocrinol. Lett. 1999;20(1–2):11–7.
Xia Q-P, Cheng Z-Y, He L. The modulatory role of dopamine receptors in brain neuroinflammation. Int. Immunopharmacol. 2019 Nov;76:105908.
Xing B, Guo J, Meng X, Wei S, Li S. The dopamine D1 but not D3 receptor plays a fundamental role in spatial working memory and BDNF expression in prefrontal cortex of mice. Behav. Brain Res. 2012 Nov 1;235(1):36–41.
Xu Y, Sheng H, Bao Q, Wang Y, Lu J, Ni X. NLRP3 inflammasome activation mediates estrogen deficiency-induced depression- and anxiety-like behavior and hippocampal inflammation in mice. Brain. Behav. Immun. 2016 Aug 1;56:175–86.
Xu Y, Sheng H, Tang Z, Lu J, Ni X. Inflammation and increased IDO in hippocampus contribute to depression-like behavior induced by estrogen deficiency. Behav. Brain Res. 2015 Jul 15;288:71–8.
Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. 2015 Jan 15;160(1–2):62–73.
Yao J, Pan Y, Ding M, Pang H, Wang B. Meta-analysis shows dopamine receptor D1 gene polymorphism is associated with bipolar disorder but not with schizophrenia. Psychiatry Res. 2013 Dec 30;210(3):1324–5.
Yin M, Chen Y, Zheng H, Pu T, Marshall C, Wu T, et al. Assessment of mouse cognitive and anxiety-like behaviors and hippocampal inflammation following a repeated and intermittent paradoxical sleep deprivation procedure. Behav. Brain Res. 2017 15;321:69–78.
You Z, Luo C, Zhang W, Chen Y, He J, Zhao Q, et al. Pro- and anti-inflammatory cytokines expression in rat’s brain and spleen exposed to chronic mild stress: involvement in depression. Behav. Brain Res. 2011 Nov 20;225(1):135–41.
Zager A, Brandão WN, Margatho RO, Peron JP, Tufik S, Andersen ML, et al. The wake-promoting drug Modafinil prevents motor impairment in sickness behavior induced by LPS in mice: Role for dopaminergic D1 receptor. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2018 Feb 2;81:468–76.
Zhang Y, Jiang X, Qin C, Cuevas S, Jose PA, Armando I. Dopamine D2 receptors’ effects on renal inflammation are mediated by regulation of PP2A function. Am. J. Physiol. Renal Physiol. 2016 Jan 15;310(2):F128-134.
Zhou X, Gan T, Fang G, Wang S, Mao Y, Ying C. Zeaxanthin improved diabetes-induced anxiety and depression through inhibiting inflammation in hippocampus. Metab. Brain Dis. 2018;33(3):705–11.
Zhou X, Zhang F, Hu X, Chen J, Tang R, Zheng K, et al. Depression can be prevented by astaxanthin through inhibition of hippocampal inflammation in diabetic mice. Brain Res. 2017 Feb 15;1657:262–8.
Zielinski MR, Kim Y, Karpova SA, McCarley RW, Strecker RE, Gerashchenko D. Chronic sleep restriction elevates brain interleukin-1 beta and tumor necrosis factor-alpha and attenuates brain-derived neurotrophic factor expression. Neurosci. Lett. 2014 Sep 19;580:27–31.